Pharmaceuticals News
Subscribe to pharmaceutical news about research, development, manufacturing and marketing of prescription and over the counter drugs. Find the latest on FDA approvals, compliance, competition, management and distribution of pharmaceutical products as well as pharmaceutical business intelligence.
CytoTest and Uniformed Services University’s Center for Prostate Disease Research Enter Into CRADA to Advance Cancer Diagnosis and Prognosis
CytoTest Inc., the Uniformed Services University of the Health Sciences (USU), and The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF) announced today that they have signed a Cooperative Research and Development Agreement (CRADA). Under the terms of the CRADA,... - March 31, 2015 - CytoTest Inc.
Alliance for Aging Research: New Survey Shows Americans Prefer Education Over Restricted Access When It Comes to OTC Pain Medications
A new survey of 1,600 Americans ages 18 and over found that adults overwhelmingly prefer education about the safe use of over-the-counter (OTC) medications, particularly those containing acetaminophen, and disagree with restricting access to those same OTC medications as the alternative. - March 25, 2015 - Alliance for Aging Research
Accredited Drug Testing Inc. Acquires Scheduleadrugtest.com
Accredited Drug Testing Inc, one of the Nation’s leading providers of drug, alcohol, DNA testing and background check screenings announced that it has acquired full ownership of Scheduleadrugtest.com, Scheduleadrugtest.com is a drug and alcohol testing online scheduling resource for employers and individuals in need of a drug or alcohol test. - March 24, 2015 - Accredited Drug Testing Inc
Recursion Pharmaceuticals Announces Funding Support for Ataxia-Telangiectasia
Recursion today announced a grant from the AT-Children's Project to advance it's innovative drug discovery work towards identifying novel treatments for ataxia-telangiectasia, a brutal childhood genetic disease. - March 20, 2015 - Recursion Pharmaceuticals
GTL Partners Obtains Exclusive Rights to Sell and License a New HCV Treatment Patent
A new HCV treatment patent has just been obtained by GTL Partners, which will hold the exclusive rights to sell and license to interested parties. - March 20, 2015 - GTL Partners
China Patent for Therapeutic Vaccine Treatment of Obesity to be Granted to Braasch Biotech
China's State Intellectual Property Office to grant Braasch Biotech's patent on Therapeutic treatment of human and pet obesity. - March 13, 2015 - Braasch Biotech LLC
Agenda Announced for Clinical Trial Performance Seminar
The seminar on March 20th will provide practical guidance on how to better assess and improve trials. - March 08, 2015 - CRO Analytics
Highland Pharms Announces New Product Launch of Highland Pharms CBD Hemp Oil and Vape Products
Highland Pharms announces the launch of their premium line of CBD Hemp oil products that are among the most affordable. Will be sold online exclusively at WellSpring CBD Oil and via brick and mortar locations including doctors' offices, vape shops, health salons and more. - March 05, 2015 - Highland Pharms CBD
Metrics Contract Services Wins Multiple CMO Leadership Awards for Innovation and Regulatory Track Record
Presented by Life Science Leader for the fourth year, the CMO Leadership Awards are based on Nice Insight research into customer awareness and perception of pharmaceutical outsourcing practices. - March 05, 2015 - Metrics, Inc.
Global Oncology Drugs Market is Expected to Reach $111.9 Billion, by 2020 - Allied Market Research
Augmentation in the prevalence and incidence rate of various cancers, growing popularity of biological and targeted modalities, along with the patent expiration of major cancer drugs are expected to drive the growth of global oncology drugs market. - February 27, 2015 - Allied Market Research
Clinigen Group Adds New Named Patient Program to Global Access Portfolio
Clinigen Group announces the latest program to be managed by Clinigen Global Access Programs (Clinigen GAP). The program will provide access to Raptor Pharmaceuticals Corp.’s PROCYSBI® (cysteamine bitartrate) for individual patients with nephropathic cystinosis. - February 20, 2015 - Clinigen Group
Medical Innovator, Bruce H. Levin, Chosen Among Thousands for a Special Times Square Appearance by America’s Registry of Outstanding Professionals
For his achievements and accomplishments in the field of pain Medicine, Dr. Bruce H. Levin of Philadelphia, Pennsylvania has been selected to appear in Times Square, New York City on February 20, 2015. This will be his second appearance; the first took place on November 28, 2014. - February 18, 2015 - America's Registry of Outstanding Professionals
LUZ Sponsors DA4S West Conference
Woman-owned life science translation company continues support of Diversity Alliance for Science event. - February 16, 2015 - LUZ, Inc.
Clinigen Appointed by AstraZeneca to Manage International Global Access Program for New Combination Antibiotic, CAZ-AVI
Clinigen Group plc announce the initiation of an international global access program for AstraZeneca’s investigational antibiotic, CAZ-AVI (ceftazidame-avibactam), through its specialist Clinigen GAP division. CAZ-AVI is being developed to treat a broad range of Gram-negative bacterial infections which are becoming resistant to antibiotics and pose an increasing risk to public health. - February 13, 2015 - Clinigen Group
CRO Analytics Named “Company to Watch” by PACT 22nd Annual Enterprise Awards
CRO Analytics, the leading provider of validated clinical trial performance data, was recognized as a “Company to Watch” by the Greater Philadelphia Alliance for Capital and Technologies (PACT) 2015 Enterprise Awards. The Enterprise Awards remain the region's most prestigious business... - February 13, 2015 - CRO Analytics
Nancy Santanello, MD, MS to Speak at CRO Analytics’ Seminar on Clinical Trial Performance
The former Merck VP of Epidemiology will present on "Including Patient-Centricity in Clinical Research." - February 06, 2015 - CRO Analytics
Studies Indicate That Vitamin K2 Protects Against Coronary Heart Disease
Worldwide, cardiovascular diseases are the number one cause of death (1), with over 7 million deaths each year attributed to the specific cardiovascular disease, coronary heart disease (CHD)2. CHD, the main cause of heart attacks (3), results from atherosclerosis, the narrowing of the inside of the... - February 04, 2015 - Innerzyme
Landmark Global Salary Report Released by Medical Science Liaison Society
Survey Includes Over 1,350 MSLs, MSL Managers, Medical Affairs Executives from 65 Countries - January 31, 2015 - Thought Leader Select
Pharma CMOs Left Behind as Biosimilars Heat Up
CMOs must provide value beyond capacity to secure contracts, new PharmSource report says. - January 31, 2015 - PharmSource
IQ4I Research & Consultancy Published a New Report on “Active Pharmaceutical Ingredients Global Market": Estimated to be Worth $173.5 Billion by 2020
The global Active Pharmaceutical Ingredients market is expected to reach $173.5 billion by 2020. This report analyzes the API market in terms of market revenue ($ Billion) for all segments, analysis is performed by synthesis type (Synthetic Chemicals API, Biotech API, HPAPI), Business type (Captive and Merchant) and therapeutic applications. - January 27, 2015 - IQ4I Research & Consultancy Pvt. Ltd.
Chinese Pharma Growth Slowed Further in 2014 But Still Impressive
In general the Chinese pharmaceutical sector saw slower but still double-digit growth in 2014 despite a host of challenges stemmed from slowing Chinese economy, regulatory shakeups, cost containment measures and price cuts, as well as healthcare reform turbulences. The Chinese drug market (at... - January 25, 2015 - WiCON International Group LLC
CRO Analytics to Host Seminar on Assessing and Improving Clinical Trial Performance
The seminar on March 20th will provide practical guidance on how to better assess and improve trials. - January 23, 2015 - CRO Analytics
LUZ Relocates Swiss Office
Global life science translation service provider moves to larger facility in Switzerland. - January 22, 2015 - LUZ, Inc.
Boston Healthcare Appoints Andreas H. Sander as Vice President and Managing Director of Boston Healthcare International GmbH
Boston Healthcare today announced the appointment of Andreas Sander as Vice President and Managing Director for Boston Healthcare International GmbH, leading the European team and the firm’s activities in Germany and Europe out of Boston Healthcare’s Berlin office. Mr. Sander brings... - January 21, 2015 - Boston Healthcare
Verix Reveals Pharma & Big Data Challenges and Predictions for 2015
Industry Leaders Share their Insights on What Mandatory Shakings are Required to Get the Market Rolling in Influencers Outlook. - January 20, 2015 - Verix
Pyramid Healthcare Solutions’ CEO to Participate at NACDS Regional Chain Conference
Pyramid Healthcare Solutions, an Avantha Group company, today announced that the company will participate in a speaking engagement at the National Association of Chain Drug Stores (NACDS) Regional Chain Conference, February 1-3, 2015, at the Ritz-Carlton in Naples, FL. Alan G Santos, Chief... - January 18, 2015 - Pyramid Healthcare Solutions
Global Erythropoietin Drugs Market is Expected to Reach $11.9 Billion by 2020 - Allied Market Research
Rising incidences of Cancer, ESRD (End Stage Renal Disease), and HIV have largely contributed to the overwhelming demand for EPO drugs. - January 18, 2015 - Allied Market Research
Applied Clinical Trials Publishes CRO Analytics Research on Measuring Clinical Trial Quality
Article explores first scientifically-validated method for measuring clinical trial performance and quality. - January 17, 2015 - CRO Analytics
Announcing Drug Safety Navigator's Acquisition of Five Oaks Pharm
Drug Safety Navigator, LLC is pleased to announce the acquisition of specialized drug safety and pharmacovigilance provider, Five Oaks Pharm, LLC. - January 15, 2015 - Drug Safety Navigator, LLC
Braasch Biotech Bolsters Intellectual Property with Patent Acceptance in the Philippines
Braasch Biotech LLC continues patent portfolio expansion with new issue in the Philippines. Novel technologies allow safe enhancement of livestock productivity by use of vaccination rather than exogenous pharmaceuticals. - January 15, 2015 - Braasch Biotech LLC
Pharma In-Licensing of NMEs Signals New Business for Contract Manufacturers
PharmSource report identifies and explains new insights based on NME approval data. - January 14, 2015 - PharmSource
Robert Buckhannon to Open Genetics Laboratories Las Vegas, Phoenix, West Palm Beach
Dr. Robert Lyle Buckhannon (Rob Buckhannon) is planning on opening genetics laboratories in three new locations. Dr. Buckhannon, an executive for the Clinical Testing Corporation is excited to announce the three new locations. Dr. Robert Buckhannon has stated that this won’t only bring jobs to the areas, but will focus on creating better patient outcomes and groundbreaking healthcare discoveries. - January 13, 2015 - Dr. Robert Buckhannon
Verix Highlights 12 of the Most Important Trends and Events That Influenced the Pharma Industry in 2014
2014 has witnessed innovative disruption in healthcare and life sciences industries. This, therefore, calls for celebration in honor of the value and contributions that healthcare companies and organizations have offered us this year. To recognize of these milestones that have impacted us in 2014, Verix has decided to share these 12 important events that played a role in Pharma industry in a number of ways. - December 29, 2014 - Verix
Sports Medicines Market - The U.S. Industry Analysis and Forecast to 2020, New Research Report by Persistence Market Research
Persistence Market Research Pvt. Ltd is released new forthcoming report on "Sports Medicines Market: The U.S. Industry Analysis and Forecast to 2020." - December 25, 2014 - Persistence Market Research
Global Treatment for Syndromes of Dementia and Movement Disorders Market Will Reach US $21,154.8 Million in 2020 by Persistence Market Research
Increasing prevalence of neurodegenerative disorders, rising awareness about mental diseases, and growing R&D investments in drug discovery and developments are the key driving factors of the treatment for syndromes of dementia and movement disorders market. - December 17, 2014 - Persistence Market Research
Paras Biopharmaceuticals Wins International Award
Paras Biopharmaceuticals wins the 2014 European Biopharmaceuticals Technology Innovation Leadership Award by Frost & Sullivan. - December 11, 2014 - Paras Biopharmaceuticals Finland Oy
Essjay Solutions Presenting at 4th Annual Pharmacovigilance Conference in Dubai
Essjay Solutions are pleased to announce they will be presenting at the 4th Annual Pharmacovigilance Conference organised by MCO on 15th January 2015 in Dubai. This conference aims to improve awareness of pharmacovigilance from a theoretical and practical point of view, as well as introduce successful models and experience in pharmacovigilance in the Middle East. - December 04, 2014 - Essjay Solutions
Verix Announces New Analytical Story Generator for Fast Sharing of Insights and Improved Decision Making
Cloud Analytics Platform Gives Pharma Commercial Operations Unmatched Ability to Create and Share Analytical Stories out of Complex Data. - December 03, 2014 - Verix
Innovation Direct™ Heading Up Marketing Campaign for ComPILLability Invention
An innovative and highly essential medical smart phone application, the ComPILLability, has been developed by Candice James of Clinton, Utah. The invention’s unique features enable it to serve as a potentially life-saving device for those who take medications. The ComPILLability helps to... - December 01, 2014 - Innovation Direct, Inc.
Charles Stiefel Named Vice Chair of Duke Medicine Board of Visitors
Victor Dzau, M.D., Chancellor of the Duke University Health System, appointed Charles Stiefel as Vice Chair of the Board of Visitors and member of the 3-person Executive Committee. The Board of Visitors assists the chancellor for health affairs, senior vice chancellor for academic affairs, and the... - November 23, 2014 - Charles Stiefel Philanthropy
Flagler Hospital and BayView Healthcare Collaborate for Better Patient Care
Use of Avancen MOD Corporation’s Innovative “Medication on Demand” Device Allows Hospital and Skilled Nursing Facility to Collaborate to Improve Patient Pain Management. - November 19, 2014 - Avancen MOD Corporation
LUZ and Pfizer to Jointly Speak at 15th Annual eDM
Monique Rivas of LUZ and Katy Juliet Page, M.B.A. of Pfizer will Copresent at DIA Conference. - November 19, 2014 - LUZ, Inc.
Experimentica Ltd Announces a Strategic Partnership with the Research and Development Center for Ophthalmic Innovations SILK, Tampere, Finland
Experimentica Ltd., a Finland-based ophthalmic CRO, announces a strategic partnership with The Research and Development Center for Ophthalmic Innovations SILK, Tampere, Finland. SILK is a research network composed of research units engaged in basic and clinical eye and vision research. Dr. Giedrius... - November 19, 2014 - Experimentica Ltd
John T. Spitznagel Has Been Recognized by America’s Registry of Outstanding Professionals
John T. Spitznagel of Glen Burnie, Maryland is a lifetime member of America’s Registry of Outstanding Professionals. He was selected to be in America’s Roundtable for his accomplishments in the field of Healthcare Sales and Marketing in 2014. Mr. Spitznagel has now been awarded the Bio of the Month membership for February 2015. - November 11, 2014 - America's Registry of Outstanding Professionals
Metrics Scientist Presents Case Study at AAPS on Merits of Trying and Testing
Dr. Anshul Gupte, associate director of pharmaceutical development, has evaluated the correlation between the type of binder used in the formulation on the roller compaction processing parameters and subsequent tablet properties. - November 08, 2014 - Metrics, Inc.
PioneerRx Pharmacy Software System Launches Full Support of Apple Pay
PioneerRx is excited to announce they fully support Apple Pay and will immediately deliver the service to their customers. Apple Pay is a new category of service designed to supply consumers with safe, secure, and easy mobile payments. Apple Pay utilizes NFC (Nearfield Communication) technology and... - November 07, 2014 - PioneerRx
ABR Launches New Mycoplasma Testing Services
ABR (now a VMRD division) announced today the availability of new testing services that can detect the presence of mycoplasma in animal origin products, master virus seeds, and other sample types. The new services satisfy various regulatory standards including US Pharmacopoeia (USP), European... - November 04, 2014 - VMRD, Inc.
DPS Consulting, Inc. Supports 16th Annual Southeast BIO Investor & Partnering Forum; Firm to Work with Life Science Industry Players from Across the Region
DPS Consulting, Inc. (DPSC) of Research Triangle Park, NC is proud to be a key sponsor at the Southeast BIO (SEBIO) Investor & Partnering Forum in Atlanta November 11-13, 2014. The sponsorship represents the value-add support DPSC continues to offer emerging and growing biotech and... - October 31, 2014 - DPS Consulting, Inc.
American Discount Pharmacy is an Award Winning Pharmacy, Winning Pharmacy of the Year for 2014 - Immokalee SW Florida and Has Been Featured on Wink and Fox TV
American Discount Pharmacy has some of the best prices in the Nation on FDA-approved and USA-based medications. The pharmacy boasts the largest free medication list at americanfreemeds.com and has a rewards card for buy one over-the-counter product, get one free. The Corporation has a Price Match Guarantee plus 10% less and lists popular RX prices on americandiscountpharmacy.net. Compound specialty Pet & Human Rxs are up to 75% off with free shipping. - October 30, 2014 - American Discount Pharmacy
Metrics Contract Services Scientist Awarded Patent for Zero-Order Release Tablet Technology
Dr. Brad Gold, vice president of pharmaceutical development, has received a U.S. patent for his intellectual property about controlled release technology. - October 30, 2014 - Metrics, Inc.